June 10, 2008, FFF Enterprises, Inc., Temecula, CA (www.VaxAmerica.com): FFF Enterprises, Inc., the nation’s largest and most trusted distributor of vaccines, plasma products and other biopharmaceuticals, announced today a new distribution model for vaccine supply and delivery.

VaxAmerica, a new vaccine program, is a nationwide network of care sites that makes vaccine distribution and administration – even for those difficult-to-get vaccines – easy, convenient and cost-effective for patients, healthcare providers and health insurers.

“VaxAmerica solves many of the issues that often make it difficult or costly for healthcare providers to stock, and for patients to receive the preventive vaccines that are an investment in long-term health,” said Nancy Creadon, senior vice president, VaxAmerica.

Many physicians choose not to stock numerous preventative vaccines due to issues such as cost, reimbursement, storage concerns and Medicare guidelines.  For patients, getting a recommended vaccine that is not stocked by their physician often means two doctor visits – one to prescribe the vaccine and a second for its administration. This results in two co-pays, and health insurers then incur two charges.

Reimbursement is also a factor for everyone in the vaccine supply chain.  Whether it is the patient or provider who has to pay out-of-pocket and then file a claim, or the health insurer who must deal with these paper claims, the vaccine reimbursement scenario can be cumbersome and costly.

“VaxAmerica makes it easy for all stakeholders by combining the cost of the vaccine and its administration into one co-pay for the patient, and one charge for the insurer.  Reimbursement is also taken care of through the network so healthcare providers and patients no longer have out-of-pocket expense, other than the patient’s co-pay, and paper claims are eliminated,” continued Creadon.  For physicians, ‘just-in-time’ delivery removes the necessity to build inventory or deal with long-term storage concerns. 

“Compliance and outcomes reporting also create a unique value proposition for health insurance plans,”said Nik Vojicic, senior vice president, managed care, FFF Enterprises, Inc.  “This is especially important to multi-administration vaccines (HPV, Hep A, Hep B) to ensure that patients are taking the preventive vaccine as prescribed and healthcare dollars are not being wasted due to a lack of compliance.” 

Vaccine producers are also well-served through the VaxAmerica network which delivers not only access, choice and convenience, but also the communication and education to make sure that specialty dosing and timing guidelines are followed.
“VaxAmerica represents a unique vehicle for vaccine manufacturers by removing the financial risks and other access impediments from the supply chain so that patients can receive the preventive vaccines,” said Chris Ground, senior vice president, FFF Enterprises, Inc.

A secure vaccine supply for the VaxAmerica network is assured through parent company, FFF Enterprises’ Guaranteed Channel Integrity™.  Now in its 20th counterfeit-free year, FFF has built a reputation on its secure channel that guarantees the products it distributes are not compromised anywhere in the supply chain.

“Patient safety has always been our primary focus,” stated Patrick M. Schmidt, president and chief executive officer, FFF Enterprises, Inc.  “We understand that the products we handle are ultimately going to be given to a patient somewhere, so we take the vaccine supply chain integrity very seriously, and have put measures into place to make certain there are no weak links,” he continued. 

FFF has protected nearly 100 million people to date through its secure vaccine distribution channel.  Schmidt is a noted speaker on issues that include biopharmaceutical distribution, supply chain integrity and drug counterfeiting security.

About FFF Enterprises, Inc.
FFF Enterprises, Inc., a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S.   Founded in 1988, FFF is celebrating its 20th year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s MyFluVaccine (www.MyFluVaccine.com) offers a dedicated flu vaccine supply, delivered to customers on the date of their choosing. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel.  FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

With its nationwide network of care sites, VaxAmerica offers access, choice, convenience and cost savings to patients, healthcare providers, health insurers and employers.

Contact: Sheryl Perez
(951) 296-2500 x1357